These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1822967)

  • 21. Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge.
    Osterhaus A; de Vries P; Morein B; Akerblom L; Heeney J
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1507-10. PubMed ID: 1466991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A formalin inactivated whole SIVmac vaccine in Ribi adjuvant protects against homologous and heterologous SIV challenge.
    Putkonen P; Thorstensson R; Cranage M; Nilsson C; Ghavamzadeh L; Albert J; Greenaway P; Biberfeld G
    J Med Primatol; 1992; 21(2-3):108-12. PubMed ID: 1433260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prototype AIDS vaccine works in monkeys.
    Am Pharm; 1990 Feb; NS30(2):5. PubMed ID: 2106250
    [No Abstract]   [Full Text] [Related]  

  • 24. Simian retrovirus vaccines: simian retrovirus and simian immunodeficiency lentivirus.
    Gardner MB; Luciw PA; Sawai ET; Marthas ML; Miller CJ; McChesney MB; Lerche NW; Pedersen NC
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):399-401. PubMed ID: 8882318
    [No Abstract]   [Full Text] [Related]  

  • 25. A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys.
    Murphey-Corb M; Martin LN; Davison-Fairburn B; Montelaro RC; Miller M; West M; Ohkawa S; Baskin GB; Zhang JY; Putney S
    Dev Biol Stand; 1990; 72():273-85. PubMed ID: 2282987
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
    Heeney JL; de Vries P; Dubbes R; Koornstra W; Niphuis H; ten Haaft P; Boes J; Dings ME; Morein B; Osterhaus AD
    J Med Primatol; 1992; 21(2-3):126-30. PubMed ID: 1433263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines.
    Panicali DL; Mazzara G; Sullivan JL; Hesselton R; Shen L; Letvin N; Daniel M; Desrosiers R; Stott EJ
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1449. PubMed ID: 1466979
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunization of rhesus monkeys with high- and low-dose Tween-ether-disrupted SIVMAC.
    Voss G; Stahl-Hennig C; Petry H; Coulibaly C; Nick S; Fuchs D; Wachter H; Lüke W; Hunsmann G
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1397-400. PubMed ID: 1466966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simian immunodeficiency virus live and inactivated experimental vaccines.
    Norley S; Beer B; Binninger-Schinzel D; Vogel T; Siegel F; Cosma C; König H; Megede JZ; Kurth R
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):447-9. PubMed ID: 8882331
    [No Abstract]   [Full Text] [Related]  

  • 30. The ability of certain SIV vaccines to provoke reactions against normal cells.
    Langlois AJ; Weinhold KJ; Matthews TJ; Greenberg ML; Bolognesi DP
    Science; 1992 Jan; 255(5042):292-3. PubMed ID: 1549775
    [No Abstract]   [Full Text] [Related]  

  • 31. Does preserving memory correlate with surviving HIV?
    Horton H; De Rosa SC
    Trends Microbiol; 2007 Jan; 15(1):1-3. PubMed ID: 17112728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.
    Lifson JD; Rossio JL; Piatak M; Bess J; Chertova E; Schneider DK; Coalter VJ; Poore B; Kiser RF; Imming RJ; Scarzello AJ; Henderson LE; Alvord WG; Hirsch VM; Benveniste RE; Arthur LO
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):772-87. PubMed ID: 15307924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine advance: monkeys still infected, but protected from illness.
    James JS
    AIDS Treat News; 2000 Oct; (353):2-3. PubMed ID: 12173554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies.
    O'Connor DH; Allen TM; Watkins DI
    DNA Cell Biol; 2002 Sep; 21(9):659-64. PubMed ID: 12396608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
    Mills KH; Page M; Chan WL; Kitchin P; Stott EJ; Taffs F; Jones W; Rose J; Ling C; Silvera P
    J Med Primatol; 1992; 21(2-3):50-8. PubMed ID: 1433267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
    Marthas ML; Miller CJ; Sutjipto S; Higgins J; Torten J; Lohman BL; Unger RE; Ramos RA; Kiyono H; McGhee JR
    J Med Primatol; 1992; 21(2-3):99-107. PubMed ID: 1433273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of protection from SIV challenge identified in monkeys.
    von Bubnoff A
    IAVI Rep; 2011; 15(3):20. PubMed ID: 21809804
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunization of macaque monkeys with low- and high-dose regimens of SIVmac results in different immune responses.
    Dittmer U; Bodemer W; Hunsmann G; Voss G
    Immunol Today; 1994 Feb; 15(2):90-1. PubMed ID: 8155269
    [No Abstract]   [Full Text] [Related]  

  • 39. SIV vaccine protection of rhesus monkeys.
    Gardner MB; Carlson JR; Jennings M; Rosenthal A; Langlois A; Haynes B; Bolognesi D; Palker TJ
    Biotechnol Ther; 1991; 2(1-2):9-19. PubMed ID: 1845125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization.
    Biberfield G; Putkonen P; Thorstensson R; Norrby E
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1511-3. PubMed ID: 1466992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.